Depression, anxiety and asthenia in patients with comorbidity of chronic heart failure and iron deficiency

Abstract

BACKGROUND: A common comorbid pathology in patients with chronic heart failure is iron deficiency, as well as depressive and anxiety disorders.

AIM: To study the frequency and severity of depression, anxiety and asthenia in patients with heart failure and iron deficiency.

MATERIALS AND METHODS: 290 patients, 78 men and 212 women (mean age 71.29 ± 8.11 years) with chronic heart failure, functional class II–IV, have been examined. All the patients underwent clinical examination, a 6-minute walk test; a general blood test, the level of NT-proBNP, iron, transferrin, and ferritin in blood serum have been studied; the percentage of transferrin saturation with iron has been calculated. The presence of iron deficiency has been diagnosed on the basis of the following criteria: a decrease in the level of serum ferritin (less than 100 μg/L) or ferritin in the range from 100 to 299 μg/L and saturation of transferrin with iron less than 20 %. Hospital anxiety and depression scale (HADS) has been used to determine the presence and severity of depression and anxiety in points; the presence and severity of asthenia have been evaluated according to MFI-20 asthenia scale.

RESULTS: It has been found that in patients with chronic heart failure and iron deficiency, depression and anxiety are diagnosed significantly more often than in patients without iron deficiency. In addition, in patients with iron deficiency, the severity of depression, anxiety and various manifestations of asthenia are significantly greater.

CONCLUSIONS: In chronic heart failure, iron deficiency predisposes patients to the development of depression and anxiety and an increase in various manifestations of asthenia.

Keywords

heart failure / iron deficiency / depression / anxiety / asthenia

References

[1] Kurz K, Lanser L, Seifert M, et al. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure. ESC Heart Fail. 2020;7(4):1880–1890. DOI: 10.1002/ehf2.12755

[2] Kurz K., Lanser L., Seifert M. et al. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure // ESC Heart Fail. 2020. Vol. 7, No. 4. P. 1880–1890. DOI: 10.1002/ehf2.12755

[3] Moliner P, Enjuanes C, Tajes M, et al. Association between norepinephrine levels and abnormal iron status in patients with chronic heart failure: is iron deficiency more than a comorbidity? J Am Heart Assoc. 2019;8(4):e010887. DOI: 10.1161/JAHA.118.010887

[4] Moliner P., Enjuanes C., Tajes M. et al. Association between norepinephrine levels and abnormal iron status in patients with chronic heart failure: is iron deficiency more than a comorbidity? // J. Am. Heart Assoc. 2019. Vol. 8, No. 4. P. e010887. DOI: 10.1161/JAHA.118.010887

[5] Smirnova MP, Chizhov PA, Baranov AA, Ivanova YI. Parameters of intracardiac hemodynamics in iron deficiency in patients with chronic heart failure. Herald of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):109–115. (In Russ.). DOI: 10.17816/mechnikov62378

[6] Смирнова М.П., Чижов П.А., Баранов А.А., Иванова Ю.И. Параметры внутрисердечной гемодинамики при дефиците железа у пациентов с хронической сердечной недостаточностью // Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2021. Т 13, № 1. С. 109–115. DOI: 10.17816/mechnikov62378

[7] Beattie JM, Khatib R, Phillips CJ, Williams SJ. Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study. Open Heart. 2020;7(1):e001153. DOI: 10.1136/openhrt-2019-001153

[8] Beattie J.M., Khatib R., Phillips C.J., Williams S.J. Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study // Open Heart. 2020. Vol. 7, No. 1. P. e001153. DOI: 10.1136/openhrt-2019-001153

[9] von Haehling S, Ebner N, Evertz R, et al. Iron deficiency in heart failure: an overview. JACC Heart Fail. 2019;7(1):36–46. DOI: 10.1016/j.jchf.2018.07.015

[10] von Haehling S., Ebner N., Evertz R. et al. Iron deficiency in heart failure: an overview // JACC Heart Fail. 2019. Vol. 7, No. 1. P. 36–46. DOI: 10.1016/j.jchf.2018.07.015

[11] González-Costello J, Comín-Colet J, Lupón J, et al. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study. BMC Cardiovasc Disord. 2018;18(1):206. DOI: 10.1186/s12872-018-0942-x

[12] González-Costello J., Comín-Colet J., Lupón J. et al. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study // BMC Cardiovasc. Disord. 2018. Vol. 18, No. 1. P. 206. DOI: 10.1186/s12872-018-0942-x

[13] Efremova EV, Sabitov IA. Komorbidnost’ i kliniko-psikhologicheskoe funktsionirovanie bol’nykh khronicheskoy serdechnoy nedostatochnost’yu. Russian Heart Failure Journal. 2015;16(2(98)):111–117. (In Russ.)

[14] Ефремова Е.В., Сабитов И.А. Коморбидность и клинико-психологическое функционирование больных хронической сердечной недостаточностью // Сердечная Недостаточность. 2015. Т. 16, № (2(98)). С. 111–117.

[15] Larina VN, Bart BYa. Anxiety-depressive states in elderly patients with chronic heart failure. Kardiologiya. 2012;52(10):26–33. (In Russ.)

[16] Ларина В.Н., Барт Б.Я. Тревожно-депрессивное состояние у больных с хронической сердечной недостаточностью пожилого возраста // Кардиология. 2012. Т. 52, № 10. С. 26–33.

[17] Yi S, Nanri A, Poudel-Tandukar K, et al. Association between serum ferritin concentrations and depressive symptoms in Japanese municipal employees. Psychiatry Res. 2011;189(3):368–72. DOI: 10.1016/j.psychres.2011.03.009

[18] Yi S., Nanri A., Poudel-Tandukar K. et al. Association between serum ferritin concentrations and depressive symptoms in Japanese municipal employees // Psychiatry Res. 2011. Vol. 189, No. 3. P. 368–372. DOI: 10.1016/j.psychres.2011.03.009

[19] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016;18(8):891–975. DOI: 10.1002/ejhf.592

[20] Ponikowski P., Voors A.A., Anker S.D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) // Eur. J. Heart Fail. 2016. Vol. 18, No. 8. P. 891–975. DOI: 10.1002/ejhf.592

[21] Saltiel PF, Silverstein DI. Major depressive disorder: mechanism-based prescribing for personalized medicine. Neuropsychiatr Dis Treat. 2015;11:875–888. DOI: 10.2147/NDT.S73261

[22] Saltiel P.F., Silverstein D.I. Major depressive disorder: mechanism-based prescribing for personalized medicine // Neuropsychiatry. Dis. Treat. 2015. Vol. 11. P. 875–888. DOI: 10.2147/NDT.S73261

[23] Nnah IC, Wessling-Resnick M. Brain iron homeostasis: a focus on microglial iron. Pharmaceuticals (Basel). 2018;11(4):129–155. DOI: 10.3390/ph11040129

[24] Nnah I.C., Wessling-Resnick M. Brain iron homeostasis: a focus on microglial iron // Pharmaceuticals (Basel). 2018. Vol. 11, No. 4. P. 129–155. DOI: 10.3390/ph11040129

[25] Maeder MT, Khammy O, Remrdios C, Kaye DM. Myocardial and systemic iron depletion in heart failure: implicatins for anemia accompanying heart failure. J Am Coll Cardiol. 2011;58(5):474–480. DOI: 10/1016/j.jacc.2011.01.059

[26] Maeder M.T., Khammy O., Remrdios C., Kaye D.M. Myocardial and systemic iron depletion in heart failure: implicatins for anemia accompanying heart failure // J. Am. Coll. Cardiol. 2011. Vol. 58, No. 5. P. 474–480. DOI: 10/1016/j.jacc.2011.01.059

RIGHTS & PERMISSIONS

Smirnova M.P., Chizhov P.A., Baranov A.A.